MAPT and Alzheimer disease: These findings underscore necroptosis as an upstream and regulated driver of neurodegeneration, integrally associated with key pathological features of AD, including amyloid-beta deposition, tau hyperphosphorylation, synaptic loss, and chronic neuroinflammation.